Frontiers in Medicine (Oct 2020)
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)
- Bahaa Abu-Raya,
- Giovanni Battista Migliori,
- Miguel O'Ryan,
- Kathryn Edwards,
- Antoni Torres,
- Jan-Willem Alffenaar,
- Jan-Willem Alffenaar,
- Jan-Willem Alffenaar,
- Anne-Grete Märtson,
- Rosella Centis,
- Lia D'Ambrosio,
- Katie Flanagan,
- Ivan Hung,
- Fulvio Lauretani,
- Chi Chi Leung,
- Elke Leuridan,
- Kirsten Maertens,
- Marcello Giuseppe Maggio,
- Simon Nadel,
- Niel Hens,
- Niel Hens,
- Hubert Niesters,
- Albert Osterhaus,
- Emanuele Pontali,
- Nicola Principi,
- Denise Rossato Silva,
- Saad Omer,
- Saad Omer,
- Antonio Spanevello,
- Nicola Sverzellati,
- Tina Tan,
- Juan Pablo Torres-Torreti,
- Dina Visca,
- Susanna Esposito
Affiliations
- Bahaa Abu-Raya
- Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
- Giovanni Battista Migliori
- Istituti Clinici Scientifici Maugeri, Istituto di Ricerca e Cura a Carattere Scientifico, Tradate, Italy
- Miguel O'Ryan
- Faculty of Medicine, Institute of Biomedical Sciences and Institute of Immunology and Immunotherapy, University of Chile, Santiago, Chile
- Kathryn Edwards
- Vanderbilt University Medical Center, Nashville, TN, United States
- Antoni Torres
- Respiratory and Intensive Care Unit, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain
- Jan-Willem Alffenaar
- Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia
- Jan-Willem Alffenaar
- Westmead Hospital, Sydney, NSW, Australia
- Jan-Willem Alffenaar
- Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, NSW, Australia
- Anne-Grete Märtson
- Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
- Rosella Centis
- Istituti Clinici Scientifici Maugeri, Istituto di Ricerca e Cura a Carattere Scientifico, Tradate, Italy
- Lia D'Ambrosio
- 0Public Health Consulting Group, Lugano, Switzerland
- Katie Flanagan
- 1University of Tasmania, Monash University, RMIT University, Hobart, Australia
- Ivan Hung
- 2Queen Mary Hospital, Hong Kong, China
- Fulvio Lauretani
- 3Geriatric Clinic Unit, Department of Medicine and Surgery, University-Hospital of Parma, University of Parma, Parma, Italy
- Chi Chi Leung
- 4Hong Kong Tuberculosis, Chest and Heart Diseases Association, Hong Kong, China
- Elke Leuridan
- 5Faculty of Medicine and Health Sciences, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium
- Kirsten Maertens
- 5Faculty of Medicine and Health Sciences, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium
- Marcello Giuseppe Maggio
- 3Geriatric Clinic Unit, Department of Medicine and Surgery, University-Hospital of Parma, University of Parma, Parma, Italy
- Simon Nadel
- 6St. Mary's Hospital, London, United Kingdom
- Niel Hens
- 7Data Science Institute, Hasselt University, Hasselt, Belgium
- Niel Hens
- 8Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
- Hubert Niesters
- 9Universitair Medisch Centrum Groningen, Groningen, Netherlands
- Albert Osterhaus
- 0University of Veterinary Medicine, Hanover, Germany
- Emanuele Pontali
- 1Department of Infectious Diseases, Galliera Hospital, Genoa, Italy
- Nicola Principi
- 2Università degli Studi di Milano, Milan, Italy
- Denise Rossato Silva
- 3Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
- Saad Omer
- 4Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, United States
- Saad Omer
- 5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States
- Antonio Spanevello
- Istituti Clinici Scientifici Maugeri, Istituto di Ricerca e Cura a Carattere Scientifico, Tradate, Italy
- Nicola Sverzellati
- 6Radiology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy
- Tina Tan
- 7Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Evanston, IL, United States
- Juan Pablo Torres-Torreti
- 8Department of Pediatrics and Pediatric Surgery, Faculty of Medicine, Dr. Luis Calvo Mackenna Hospital, University of Chile, Santiago, Chile
- Dina Visca
- Istituti Clinici Scientifici Maugeri, Istituto di Ricerca e Cura a Carattere Scientifico, Tradate, Italy
- Susanna Esposito
- 9Pediatric Clinic, Department of Medicine and Surgery, Pietro Barilla Children's Hospital, University of Parma, Parma, Italy
- DOI
- https://doi.org/10.3389/fmed.2020.572485
- Journal volume & issue
-
Vol. 7
Abstract
Coronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 2020, more than 7,000,000 COVID-19 cases have been reported worldwide, and more than 400,000 patients have died, affecting at least 188 countries. While literature on the disease is rapidly accumulating, an integrated, multinational perspective on clinical manifestations, immunological effects, diagnosis, prevention, and treatment of COVID-19 can be of global benefit. We aimed to synthesize the most relevant literature and experiences in different parts of the world through our global consortium of experts to provide a consensus-based document at this early stage of the pandemic.
Keywords
